Evidence map›Paper›PMID 29020042›Full record

ArticlePLoS neglected tropical diseases2017

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.

Dung D Pam, Dziedzom K de Souza, Susan D'Souza, Millicent Opoku, Safiya Sanda, Ibrahim Nazaradden, Ifeoma N Anagbogu, Chukwu Okoronkwo, Emmanuel Davies, Elisabeth Elhassan and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Pooled it
  4. Article
  5. Article
  6. Article
  7. LAMP in Neglected Tropical Diseases: A Focus on Parasites.Diagnostics (Basel, Switzerland) · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Assessing the Presence ofTropical medicine and infectious disease · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Dung D PamApplied Entomology and Parasitology Unit, Department of Zoology, University of Jos, Jos, Nigeria.
Dziedzom K de SouzaParasitology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.ORCID http://orcid.org/0000-0001-5000-6177
Susan D'SouzaSightsavers International, UK Office, London, United Kingdom.
Millicent OpokuParasitology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Safiya SandaSightsavers International, Nigeria Office, Kaduna, Nigeria.
Ibrahim NazaraddenSightsavers International, Nigeria Office, Kaduna, Nigeria.
Ifeoma N AnagboguNTD Division, Federal Ministry of Health, Abuja, Nigeria.
Chukwu OkoronkwoNTD Division, Federal Ministry of Health, Abuja, Nigeria.
Emmanuel DaviesNTD Division, Federal Ministry of Health, Abuja, Nigeria.
Elisabeth ElhassanSightsavers International, Nigeria Office, Kaduna, Nigeria.
David H MolyneuxCentre for Neglected Tropical Diseases and Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Moses J BockarieEuropean and Developing Countries Clinical Trials Partnership, Africa Office, Cape Town, South Africa.
Benjamin G KoudouCentre for Neglected Tropical Diseases and Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Federal Ministry of Health · NGUniversity of Ghana · GHLiverpool School of Tropical Medicine · GBSightsavers · GBUniversité Nangui Abrogoua · CIUniversity of Jos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Global Programme to Eliminate Lymphatic Filariasis (GPELF), launched in 2000, has the target of eliminating the disease as a public health problem by the year 2020. The strategy adopted is mass drug administration (MDA) to all eligible individuals in endemic communities and the implementation of measures to reduce the morbidity of those suffering from chronic disease. Success has been recorded in many rural endemic communities in which elimination efforts have centered. However, implementation has been challenging in several urban African cities. The large cities of West Africa, exemplified in Nigeria in Kano are challenging for LF elimination program because reaching 65% therapeutic coverage during MDA is difficult. There is therefore a need to define a strategy which could complement MDA. Thus, in Kano State, Nigeria, while LF MDA had reached 33 of the 44 Local Government Areas (LGAs) there remained eleven 'urban' LGAs which had not been covered by MDA. Given the challenges of achieving at least 65% coverage during MDA implementation over several years in order to achieve elimination, it may be challenging to eliminate LF in such settings. In order to plan the LF control activities, this study was undertaken to confirm the LF infection prevalence in the human and mosquito populations in three urban LGAs.

methodsThe prevalence of circulating filarial antigen (CFA) of Wuchereria bancrofti was assessed by an immuno-chromatography test (ICT) in 981 people in three urban LGAs of Kano state, Nigeria. Mosquitoes were collected over a period of 4 months from May to August 2015 using exit traps, gravid traps and pyrethrum knock-down spray sheet collections (PSC) in different households. A proportion of mosquitoes were analyzed for W. bancrofti, using dissection, loop-mediated isothermal amplification (LAMP) assay and conventional polymerase chain reaction (PCR).

resultsThe results showed that none of the 981 subjects (constituted of <21% of children 5-10 years old) tested had detectable levels of CFA in their blood. Entomological results showed that An. gambiae s.l. had W. bancrofti DNA detectable in pools in Kano; W. bancrofti DNA was detected in between 0.96% and 6.78% and to a lesser extent in Culex mosquitoes where DNA was detected at rates of between 0.19% and 0.64%. DNA analysis showed that An. coluzzii constituted 9.9% of the collected mosquitoes and the remaining 90.1% of the mosquitoes were Culex mosquitoes.

conclusionDespite detection of W. bancrofti DNA within mosquito specimens collected in three Kano urban LGAs, we were not able to find a subject with detectable level of CFA. Together with other evidence suggesting that LF transmission in urban areas in West Africa may not be of significant importance, the Federal Ministry of Health advised that two rounds of MDA be undertaken in the urban areas of Kano. It is recommended that the prevalence of W. bancrofti infection in the human and mosquito populations be re-assessed after a couple of years.

Indexed as

AdolescentAdultAnimalsAnophelesAntigens, HelminthChildCulexDisease EradicationDrug Administration ScheduleElephantiasis, FilarialFemaleFilaricidesHumansMaleMiddle AgedNigeriaAntigens, HelminthFilaricides

Identifiers

PMID29020042
PMCPMC5665554
OpenAlexW2763129913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.